ArticleJournal of clinical hypertension (Greenwich, Conn.)2021

Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first-line antihypertensive therapy.

Revathy Carnagarin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.